PS Ratio
2.25
-0.09-3.85%
3 min ago
Summary
- As of February 7, 2025, TRDA price to sales ratio is 2.25, with a fall of -0.09 (-3.85%) during the most recent trading day.
- Over the past year, TRDA PS ratio has dropped by -1.34 (-37.33%).
- TRDA PS ratio is now -90.68% below its all-time high of 24.13.
Performance
TRDA PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
TRDA PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.9% | -4.1% | -4.1% | -10.1% |
| 1 m1 month | -24.2% | -24.4% | -24.4% | - |
| 3 m3 months | -19.1% | -19.2% | -19.2% | -10.1% |
| 6 m6 months | +4.7% | -6.4% | -5.8% | - |
| ytdytd | -25.3% | -25.2% | -25.2% | - |
| 1 y1 year | -37.3% | -6.6% | +4.5% | +146.9% |
| 5 y5 years | - | - | - | - |
TRDA PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -28.3% | 2.09 | +7.7% | |
| 3 m | 3-month | 3.79 | -40.6% | 2.09 | +7.7% |
| 6 m | 6-month | 3.79 | -40.6% | 2.09 | +7.7% |
| 1 y | 1-year | 3.93 | -42.8% | 2.09 | +7.7% |
| 3 y | 3-year | 24.13 | -90.7% | 2.09 | +7.7% |
| 5 y | 5-year | 24.13 | -90.7% | 2.09 | +7.7% |
| alltime | all time | 24.13 | -90.7% | 2.09 | +7.7% |
Entrada Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 2.25(-25.2%) |
| Date | Value |
|---|---|
| 2024 | 3.01(-23.0%) |
| 2023 | 3.91 |
FAQ
- What is Entrada Therapeutics price to sales ratio?
- What is the all time high PS ratio for Entrada Therapeutics?
- What is TRDA price to sales ratio year-to-date change?
- What is Entrada Therapeutics PS ratio year-on-year change?
What is Entrada Therapeutics price to sales ratio?
The current PS ratio of TRDA is 2.25
What is the all time high PS ratio for Entrada Therapeutics?
Entrada Therapeutics all-time high price to sales ratio is 24.13
What is TRDA price to sales ratio year-to-date change?
Entrada Therapeutics price to sales ratio has changed by -0.76 (-25.25%) since the beginning of the year
What is Entrada Therapeutics PS ratio year-on-year change?
Over the past year, TRDA price to sales ratio has changed by -1.34 (-37.33%)